Skip to content

Atazanavir equal to efavirenz: new PI proves its potency, but leaves some questions

Appendicitis more common in HAART patients than general population

US study finds genital herpes near doubles risk of acquiring HIV in gay men

T-20: response limited in HIV patients with fewest drug options

Resuming nucleoside analogues after symptomatic hyperlactatemia

New HIV fusion inhibitor: T-1249 appears as potent as T-20

Drug prevents spread of genital herpes in HIV-negative heterosexuals: Lessons for HIV prevention

Emerging Therapies: Triangle present more data on FTC

ddI/d4T/abacavir: don't use it, say Danes